Literature DB >> 6819081

Evaluation of therapy with methanol extraction residue of BCG (MER).

E M Hersh, J Quesada, S G Murphy, J U Gutterman, R D Hutchins.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6819081     DOI： 10.1007/bf00199424

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN： 0340-7004            Impact factor:   6.968


× No keyword cloud information.
  24 in total

1.  Impact of specific immunotherapy in acute myelocytic leukemia.

Authors:  J G Bekesi; J F Holland
Journal:  Haematol Blood Transfus       Date:  1979

2.  Combination chemotherapy plus methanol extracted residue of bacillus Calmette-Guérin or Corynebacterium parvum in stage III lung cancer.

Authors:  S Bjornsson; H Takita; N Kuberka; H Preisler; H Catane; D Higby; E Henderson
Journal:  Cancer Treat Rep       Date:  1978-04

3.  Iv methyl-CCNU and ftorafur with or without methanol-extracted residue of BCG for metastatic adenocarcinoma of the colon.

Authors:  C H Diggs; P H Wiernik; A C Smyth
Journal:  Cancer Treat Rep       Date:  1977-11

4.  Phase I toxicity study of methanol-extracted residue of Bacillus Calmette-Guérin by the iv route.

Authors:  J A Maroun; J R Quesada; E M Hersh; J U Gutterman; S Richman; M A Schwarz; N Parker
Journal:  Cancer Treat Rep       Date:  1979 Nov-Dec

5.  Intralesional injection of the methanol extraction residue of Bacillus Calmette-Guerin (MER) into cutaneous metastases of malignant melanoma.

Authors:  S E Krown; E Y Hilal; C M Pinsky; Y Hirshaut; H J Wanebo; J A Hansen; A G Huvos; H F Oettgen
Journal:  Cancer       Date:  1978-12       Impact factor: 6.860

6.  Alternating noncross-resistant combination chemotherapy and active nonspecific immunotherapy with BCG or MER-BCG for advanced breast carcinoma.

Authors:  G R Blumenschein; G N Hortobagyi; S P Richman; J U Gutterman; C K Tashima; A U Buzdar; M A Burgess; R B Livingston; E M Hersh
Journal:  Cancer       Date:  1980-02-15       Impact factor: 6.860

7.  Chemotherapy versus chemoimmunotherapy in advanced adenocarcinoma of the colon and rectum: a prospective randomized study.

Authors:  F Richards; H B Muss; R Cooper; D R White; J J Stuart; V Howard; P Barnes; L Rhyne; C L Spurr
Journal:  Cancer       Date:  1979-01       Impact factor: 6.860

8.  Effect of immunotherapy with Corynebacterium parvum and methanol extraction residue of BCG administered intravenously on host defense function in cancer patients.

Authors:  E M Hersh; S G Murphy; J R Quesada; J U Gutterman; C R Gschwind; J Morgan
Journal:  J Natl Cancer Inst       Date:  1981-06       Impact factor: 13.506

9.  Chemotherapy vs. chemoimmunotherapy with methanol extraction residue of Bacillus Calmette-Guerin (MER) in advanced breast cancer: a randomized trial by the Piedmont Oncology Association.

Authors:  H B Muss; F Richards; M R Cooper; D R White; D V Jackson; J J Stuart; V Howard; A Shore; A L Rhyne; C L Spurr
Journal:  Cancer       Date:  1981-05-01       Impact factor: 6.860

10.  A preliminary study of intravenous methanol extraction residue of BCG in treatment of advanced cancer.

Authors:  E Robinson; A Bartal; J Honigman; Y Cohen
Journal:  Br J Cancer       Date:  1977-09       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.